NRX Pharmaceuticals, Inc. - NRXP

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 8
Latest filed: Sep 16, 2026
Form Count
8-K 7
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Sep 16, 2026 8-K Sep 15, 2026 0001437749-26-030492 View
Sep 14, 2026 8-K Sep 08, 2026 0001437749-26-030228 View
Aug 17, 2026 8-K Aug 17, 2026 0001437749-26-028111 View
Aug 07, 2026 8-K Aug 07, 2026 0001437749-26-026428 View
Jul 22, 2026 8-K Jul 21, 2026 0001437749-26-024037 View
Jun 04, 2026 8-K Jun 03, 2026 0001437749-26-019576 View
Jun 02, 2026 8-K Jun 02, 2026 0001437749-26-019196 View
May 15, 2026 SCHEDULE 13G/A — 0001193125-26-225997 View